
Embla Medical is a provider of prosthetics, neuro orthotics, bracing and supports, and patient care.
emblamedical.comCrawled Nov 8, 2026
The page lists Embla Medical investor announcements, including reports and share programs.
Paralympic gold medalist and Team Össur athlete to continue prosthetics collaboration through the Los Angeles 2028 Paralympic Games.
Embla Medical offers careers through brands that help people live a Life Without Limitations.
Embla Medical Board of Directors - Niels Jacobsen - Svafa Grönfeldt - Arne Boye Nielsen - Alberto Esquenazi - Caroline Vagner Rosenstand - Tina Abild Olesen
Embla Medical provides mobility solutions to help people live a Life Without Limitations.
Embla Medical is home to several brands renowned for positively impacting people's health and well-being, including Össur, FIOR & GENTZ & College Park Industries.
Embla Medical focuses on improving mobility to help people live a Life Without Limitations.
Embla Medical offers mobility solutions under several brands.
A leading global provider of innovative mobility solutions that help people live a Life Without Limitations.
Embla Medical requires employees to follow ethical and social responsibility guidelines, including the United Nations Global Compact.
The page is part of an email sent by Embla Medical or its subsidiaries.
The page outlines Embla Medical’s terms of use for website visitors.
Embla Medical, the Icelandic parent company of Össur, adjusts its 2026 guidance to target approximately **5% organic sales growth** for the year. The revision reflects a more conservative projection amid evolving market conditions. The company specializes in mobility solutions, including prosthetic and orthotic technologies.
Oct 2026NLSNews article
Embla Medical hf releases its interim report for Q4 and full-year 2025 financial results. The company provides an update on its performance, operational progress, and strategic initiatives in the medical technology sector. Key highlights include financial metrics and potential advancements in its core business areas.
Feb 2026PR NewswireNews article
Embla Medical hf releases its interim report for Q1 2025, detailing financial and operational updates under Sveinn Sölvason’s leadership as President and CEO. The report covers key developments in the company’s progress, though specific metrics or strategic shifts are not disclosed in the provided excerpt.
Apr 2025MFNNews article
Embla Medical hf. releases its interim report for Q4 2024, detailing financial and operational updates under Sveinn Sölvason’s leadership as President and CEO. The report covers performance metrics, strategic progress, and key developments in the company’s pipeline. Sveinn Sölvason provides commentary on the quarter’s achievements and outlook.
Feb 2025MFNNews article